269 results on '"Skuza G"'
Search Results
2. Repeated trimipramine induces dopamine D2/D3 and α1-adrenergic up-regulation
3. Antidepressant effects of pramipexole, a novel dopamine receptor agonist
4. The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain
5. Roxindole, a potential antidepressant I. Effect on the dopamine system
6. The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist
7. Erratum to: The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain
8. Memantine, amantadine, and L-deprenyl potentiate the action of L-DOPA in monoamine-depleted rats
9. Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity
10. Antidepressant drugs increase the locomotor hyperactivity induced by MK-801 in rats
11. The effect of (+)- and (−)-oxaprotiline administered repeatedly on the dopamine system
12. Oxaprotiline enantiomers given repeatedly and brain α-adrenoceptors
13. Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's disease
14. Some central pharmacological effects of (+)- and (−)-oxaprotiline
15. A potential antidepressant activity of SA4503, a selective σ1 receptor agonist
16. Effect of repeated treatment with tianeptine and fluoxetine on central dopamine D2/D3 receptors
17. Effect of repeated treatment with tianeptine and fluoxetine on the central α 1-adrenergic system
18. Antidepressants given repeatedly increase the behavioural effect of dopamine D-2 agonist
19. Pharmacological properties of EXP 561, a potential antidepressant drug
20. The influence of repeated treatment with imipramine, (+)- and (−)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists
21. Repeated treatment with antidepressant drugs increases the behavioural response to apomorphine
22. Effects of chronic treatment with antidepressants on aggressiveness induced by clonidine in mice
23. SUBSENSITIVITY OF PRESYNAPTIC AND SUPERSENSITIVITY OF POSTSYNAPTIC DOPAMINERGIC RECEPTORS AS A RESULT OF REPEATED ADMINISTRATION OF ANTIDEPRESSANT DRUGS
24. P.2.d.010 The impact of co-treatment with antidepressants and memantine on immobility time in the tail suspension test; role of σ1 receptors
25. P.2.011 Effects of combined treatment with antidepressant drugs and low dose of risperidone in animal models of depression
26. P45 CHRONIC CO-TREATMENT WITH ANTIDEPRESSANT DRUGS AND AMANTADINE INDUCES BDNF GENE EXPRESSION IN RATS
27. Behavioral Pharmacology of σ-Ligands
28. P.1.066 The interaction between selective sigmaligands and uncompetitive NMDA receptor antagonists in the forced swimming test in rats
29. P.1.065 Effect of combined treatment with imipramine and metyrapone in patients with drug-resistant ular depression - clinical and pharmacokinetic studies
30. P.1.075 Effect of combined treatment with imipramine and metyrapone on the immunological and endocrine parameters of rats subjected to the forced swimming test
31. Effect of repeated treatment with tianeptine and fluoxetine on the central α1-adrenergic system
32. The anticataleptic effect of 7-OH-DPAT: are dopamine D 3 receptors involved?
33. Repeated trimipramine induces dopamine D 2 /D 3 and α 1 -adrenergic up-regulation
34. P.1.079 The pharmacological profile of venlafaxine, a new antidepressant drug given acutely and chronically
35. The pharmacological profile of venlafaxine, a new antidepressant
36. The nephrologist's dilemma: to biopsy or not to biopsy?
37. Roxindole, a Dopamine Autoreceptor Agonist with a Potential Antidepressant Activity
38. P-3 Pramipexole, a selective dopamine receptor agonist with potential antidepressant activity
39. P-4-3 Central effects of EMD 57445, a new sigma receptor ligand with a potential antipsychotic activity
40. P-2-29 Fluoxetine, a selective 5-hydroxtryptamine uptake inhibitor, increases the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist
41. Some central behavioural effects of CNQX and NBQX, AMPA receptor antagonists
42. The effect of NMDA receptor antagonists on the neuroleptics-induced catalepsy in mice
43. Effects of MK-801 and antidepressant drugs in the forced swimming test in rats
44. EFFECTS OF CGP 37849 AND CGP 39551, THE COMPETITIVE NMDA RECEPTOR ANTAGONISTS, IN THE FORCED SWIMMING TEST
45. Antidepressant Activity of S-Adenosyl-L-Methionine in Mice and Rats
46. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
47. Antidepressant Drugs Given Repeatedly Increase the Behavioral Effects of Methoxamine.
48. Repeated trimipramine induces dopamine D2/D3 and α1-adrenergic up-regulation.
49. Central Action of Amitriptyline N-oxide.
50. Effect of repeated treatment with tianeptine and fluoxetine on the central a1-adrenergic system
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.